{
    "case_number": "CAC-UDRP-106306",
    "time_of_filling": "2024-03-05 10:08:30",
    "domain_names": [
        "novartisco.com"
    ],
    "case_administrator": "Olga Dvořáková (Case admin)",
    "complainant": [
        "Novartis AG"
    ],
    "complainant_representative": "BRANDIT GmbH",
    "respondent": [
        "Tony Stone"
    ],
    "respondent_representative": null,
    "factual_background": "<p>According to the Complainant, Novartis is one of the biggest global pharmaceutical and healthcare groups. It provides solutions to address the evolving needs of patients worldwide by developing and delivering innovative medical treatments and drugs. The Complainant, with headquarters in Switzerland, was created in 1996 through a merger of the companies Ciba-Geigy and Sandoz, and is the holding company of the Novartis group. In 2022, Novartis achieved net sales from its operations of USD 50.5 billion, and it employed approximately 102 000 full-time equivalent employees as of December 31, 2022.<\/p>\n<p>The disputed domain name &lt;novartisco.com&gt; was registered on 21 January 2023.<\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<p>The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.&nbsp;<span>The Complainant<\/span><span>&acute;s contentions are summarised below.<\/span><\/p>\n<p>No administratively compliant Response has been filed.<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Tom  Heremans"
    ],
    "date_of_panel_decision": "2024-04-23 00:00:00",
    "informal_english_translation": "<p>The Complainant is the owner of several trademarks including the word NOVARTIS, such as:<\/p>\n<ul>\n<li>The international trademark for the word NOVARTIS, registered on 1 July 1996 under No. 663765, for goods and services of the classes 1, 2, 3, 4, 5, 7, 8, 9, 10, 14, 16, 17, 20, 22, 28, 29, 30, 31, 32, 40 and 42;&nbsp;<\/li>\n<li>The international trademark for the word NOVARTIS, registered on 31 October 1996 under No. 666218, for goods and services of the classes 41 and 42;<\/li>\n<li>The European trademark for the word NOVARTIS, registered on 25 June 1999 under No. 304857, for goods and services of the classes 1, 5, 9, 10, 29, 30, 31 and 32.<\/li>\n<\/ul>\n<p>Moreover, the Complainant is also the owner of several domain names that include the word NOVARTIS, such as the domain name &lt;novartis.com&gt; registered on April 2, 1996.<\/p>",
    "decision_domains": {
        "novartisco.com": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}